Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

India's Jubilant Pharma tumbles after reporting loss in Q3

** Shares of Indian pharma and life sciences company
Jubilant Pharmova  JUBA.NS  fall as much as 10.49% to 311.60
rupees, lowest level in over four months
    ** Co reports net loss of 156.7 mln in third quarter; core
profit falls about 25% to 1.46 bln rupees from the previous year
    ** Lower COVID-19 related deals in sterile injectables
business, adverse impact on the radiopharmaceuticals business
due to generated supply outage and lower volumes in drug
discovery services business hurt the profitability, company says
    ** About 353,908 shares change hands as of 2:02 p.m. IST,
nearly quadruple the 30-day avg of 98,758 shares
    ** Of the four analysts tracking the company, two maintain
"buy" and two suggest "hold"; median TP is 406.60 rupees -
Refinitiv data
    ($1 = 82.1300 Indian rupees)
 (Reporting by Bharath Rajeswaran in Bengaluru)
 ((bharath.rajeswaran@thomsonreuters.com; Mobile:
+919769003463))

Recent news on Jubilant Pharmova

See all news